BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21214508)

  • 1. Regulatory cascades of protein phosphatases: implications for cancer treatment.
    Jailkhani N; Chaudhri VK; Rao KV
    Anticancer Agents Med Chem; 2011 Jan; 11(1):64-77. PubMed ID: 21214508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer.
    Zhang Q; Fan Z; Zhang L; You Q; Wang L
    J Med Chem; 2021 Jul; 64(13):8916-8938. PubMed ID: 34156850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tyrosine phosphatase inhibitors in cancer treatment with emphasis on SH2 domain-containing tyrosine phosphatases (SHPs).
    Irandoust M; van den Berg TK; Kaspers GJ; Cloos J
    Anticancer Agents Med Chem; 2009 Feb; 9(2):212-20. PubMed ID: 19199865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting Report Europhosphatase 2015: Phosphatases as Drug Targets in Cancer.
    Hoekstra E; Peppelenbosch MP; Fuhler GM
    Cancer Res; 2016 Jan; 76(2):193-6. PubMed ID: 27309387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of protein phosphatases in genitourinary cancers.
    Igawa T
    Int J Urol; 2017 Jan; 24(1):16-24. PubMed ID: 27577716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein phosphatase 2A as a potential target for anticancer therapy.
    Kalev P; Sablina AA
    Anticancer Agents Med Chem; 2011 Jan; 11(1):38-46. PubMed ID: 21288198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Function of Proto-oncogene Product PPM1D and Development of PPM1D Inhibitors for Cancer Chemotherapy].
    Kamada R; Chuman Y; Kozakai Y; Sakaguchi K
    Seikagaku; 2015 Oct; 87(5):531-8. PubMed ID: 26638620
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosphatases as targets for cancer treatment.
    Lazo JS; Wipf P
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1297-304. PubMed ID: 19943201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
    Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC
    Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protein phosphatase 2A: its structure, function and activity regulation].
    Liu WJ; Shen Y; Ding J
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):105-12. PubMed ID: 12545214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphatase 5 promotes hepatocarcinogenesis through interaction with AMP-activated protein kinase.
    Chen YL; Hung MH; Chu PY; Chao TI; Tsai MH; Chen LJ; Hsiao YJ; Shih CT; Hsieh FS; Chen KF
    Biochem Pharmacol; 2017 Aug; 138():49-60. PubMed ID: 28528695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of new antitumor reagents which block the cell cycle progression].
    Osada H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1541-6. PubMed ID: 9309153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation.
    Ogasawara S; Kiyota Y; Chuman Y; Kowata A; Yoshimura F; Tanino K; Kamada R; Sakaguchi K
    Bioorg Med Chem; 2015 Oct; 23(19):6246-9. PubMed ID: 26358280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viewing serine/threonine protein phosphatases through the eyes of drug designers.
    Zhang M; Yogesha SD; Mayfield JE; Gill GN; Zhang Y
    FEBS J; 2013 Oct; 280(19):4739-60. PubMed ID: 23937612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-specificity MAP kinase phosphatases as targets of cancer treatment.
    Nunes-Xavier C; Romá-Mateo C; Ríos P; Tárrega C; Cejudo-Marín R; Tabernero L; Pulido R
    Anticancer Agents Med Chem; 2011 Jan; 11(1):109-32. PubMed ID: 21288197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphatase regulation by endogenous inhibitors.
    Shenolikar S
    Semin Cancer Biol; 1995 Aug; 6(4):219-27. PubMed ID: 8541517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hanks-Type Serine/Threonine Protein Kinases and Phosphatases in Bacteria: Roles in Signaling and Adaptation to Various Environments.
    Janczarek M; Vinardell JM; Lipa P; Karaś M
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.
    Brautigan DL; Farrington C; Narla G
    Clin Sci (Lond); 2021 Jul; 135(13):1545-1556. PubMed ID: 34192314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins.
    Dawson JF; Holmes CF
    Front Biosci; 1999 Oct; 4():D646-58. PubMed ID: 10502549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.